DISINFACTS | Issue 2/2026

Broad clinical use of CHG CHG has been used in the medical field for decades, with concerns about reduced susceptibility only emerging recently. The substance has a broad antimicrobial spectrum of activity: it has a bactericidal effect at high concentrations and inhibits growth and reproduction at lower concentrations. In hospitals, CHG is commonly used for skin antisepsis in patients, particularly in the Anglo-American region, and for staff hand hygiene. Other clinical applications include antiseptic washing for residents of long-term care facilities, and the use of CHG as a mouthwash to treat gum inflammation. Furthermore, CHG is widely used in veterinary medicine [2]. CHG residues may persist in the hospital environment The study used controlled microcosm experiments to replicate the natural environment on a small scale. Although the concentration of CHG on all cleaned surfaces decreased significantly after 24 hours, it remained detectable in residual concentrations. The findings suggest that CHG can transfer from the skin to the surrounding environment and persist on surfaces despite cleaning and disinfection, often in sublethal concentrations (i.e. concentrations that do not kill clinically relevant bacteria). Among the bacteria with reduced sensitivity to CHG were opportunistic pathogens such as Pseudomonas aeruginosa. Washbasin drains in particular were found to be critical hotspots, and indoor air was identified as a possible transmission route [2]. Clinically relevant pathogens can survive CHG treatment The researchers also investigated how long four clinically relevant bacterial isolates – Escherichia coli, Klebsiella pneumoniae, Klebsiella variicola and Staphylococcus aureus – survive on plastic surfaces after being exposed to CHG for 24 hours. Five CHG concentrations corresponding to typical residual levels following cleaning or disinfection were tested. The results showed that all bacterial species survived for 24 hours on the treated surfaces, regardless of bacterial density and CHG concentration (Fig. 1). As exposure to sublethal concentrations of CHG has been linked to reduced susceptibility not only to CHG, but also to antibiotics, these findings are concerning [2]. Practical implications for hospitals The findings suggest that the widespread use of CHG should be critically reviewed, with unnecessary exposure being avoided. However, given the high clinical importance of CHG, appropriate stewardship measures and further research into alternatives are also required [2]. Bacteria can become less susceptible to antiseptics, which is a growing challenge for infection prevention. This is particularly the case for cationic, amphiphilic active substances such as quaternary ammonium compounds (QACs) or chlorhexidine digluconate (CHG). These substances can stimulate the production of non-specific efflux pumps in bacteria, which expel toxic substances such as QACs or CHG from the cell. Furthermore, these pumps enable bacteria to excrete certain antibiotics as well [1]. A recent study examined several potential risks associated with CHG use [2]. Reduced bacterial susceptibility to antiseptics: a growing concern Reconsidering the widespread use of chlorhexidine KNOWLEDGE 4

RkJQdWJsaXNoZXIy NDU5MjM=